Published in J Clin Microbiol on September 01, 1998
Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol (2006) 12.53
High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci U S A (2001) 6.97
Variable-number tandem repeat typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110 by using mycobacterial interspersed repetitive units. J Clin Microbiol (2002) 3.88
Stability of variable-number tandem repeats of mycobacterial interspersed repetitive units from 12 loci in serial isolates of Mycobacterium tuberculosis. J Clin Microbiol (2002) 2.77
Differentiation of phylogenetically related slowly growing mycobacteria by their gyrB sequences. J Clin Microbiol (2000) 2.51
An essential two-component signal transduction system in Mycobacterium tuberculosis. J Bacteriol (2000) 2.16
Rapid diagnosis of mycobacterial infections and quantitation of Mycobacterium tuberculosis load by two real-time calibrated PCR assays. J Clin Microbiol (2003) 1.46
A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927. J Bacteriol (2000) 1.26
Adaptation to environmental stimuli within the host: two-component signal transduction systems of Mycobacterium tuberculosis. Microbiol Mol Biol Rev (2011) 1.09
Use of the hupB gene encoding a histone-like protein of Mycobacterium tuberculosis as a target for detection and differentiation of M. tuberculosis and M. bovis. J Clin Microbiol (2004) 1.06
Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy. PLoS One (2011) 1.05
A single-step sequencing method for the identification of Mycobacterium tuberculosis complex species. PLoS Negl Trop Dis (2008) 1.03
Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG. PLoS One (2012) 0.84
Different strategies for molecular differentiation of Mycobacterium bovis strains isolated in Sardinia, Italy. Appl Environ Microbiol (1999) 0.83
Clinical utility of RD1, RD9 and hsp65 based PCR assay for the identification of BCG in vaccinated children. BMC Res Notes (2013) 0.83
Genomic variations associated with attenuation in Mycobacterium avium subsp. paratuberculosis vaccine strains. BMC Microbiol (2013) 0.83
Use of PCR-based Mycobacterium tuberculosis genotyping to prioritize tuberculosis outbreak control activities. J Clin Microbiol (2008) 0.80
senX3-independent contribution of regX3 to Mycobacterium tuberculosis virulence. BMC Microbiol (2014) 0.79
Multiplex PCR-identified cutaneous tuberculosis evoked by Mycobacterium bovis BCG vaccination in a healthy baby. J Clin Microbiol (2005) 0.78
Genotyping Mycobacterium bovis from cattle in the Central Pampas of Argentina: temporal and regional trends. Mem Inst Oswaldo Cruz (2014) 0.76
Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis. Emerg Infect Dis (2017) 0.75
Mycobacterium microti tuberculosis in its maintenance host, the field vole (Microtus agrestis): characterization of the disease and possible routes of transmission. Vet Pathol (2013) 0.75
Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA (1995) 15.26
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol (1996) 10.26
Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. J Appl Bacteriol (1992) 4.83
Identification of novel intergenic repetitive units in a mycobacterial two-component system operon. Mol Microbiol (1997) 3.99
Insertion element IS1081-associated restriction fragment length polymorphisms in Mycobacterium tuberculosis complex species: a reliable tool for recognizing Mycobacterium bovis BCG. J Clin Microbiol (1992) 3.99
Characterization of a major polymorphic tandem repeat in Mycobacterium tuberculosis and its potential use in the epidemiology of Mycobacterium kansasii and Mycobacterium gordonae. J Bacteriol (1992) 3.66
BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res (1984) 3.47
Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids. J Clin Microbiol (1992) 3.36
Molecular phylogeny of the Mycobacterium avium complex demonstrates clinically meaningful divisions. J Infect Dis (1994) 2.69
PCR identification of Mycobacterium bovis BCG. J Clin Microbiol (1997) 2.60
MPB70, a unique antigen of Mycobacterium bovis BCG. Am Rev Respir Dis (1984) 2.45
Differentiation of known strains of BCG from isolates of mycobacterium bovis and Mycobacterium tuberculosis by using mycobacteriophage 33D. J Clin Microbiol (1975) 2.22
Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun (1996) 1.98
Identification of a new DNA region specific for members of Mycobacterium tuberculosis complex. J Clin Microbiol (1998) 1.96
Differentiation of strains in Mycobacterium tuberculosis complex by DNA sequence polymorphisms, including rapid identification of M. bovis BCG. J Clin Microbiol (1995) 1.81
Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns. J Gen Microbiol (1986) 1.79
Second IUATLD study on complications induced by intradermal BCG-vaccination. Bull Int Union Tuberc Lung Dis (1988) 1.71
Complications of bacillus Calmette-Guérin immunotherapy. Urol Clin North Am (1992) 1.60
Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A review. Tuber Lung Dis (1992) 1.30
Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation. Clin Infect Dis (1993) 1.26
Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG. J Gen Microbiol (1983) 1.14
Limited variation of DNA fingerprints (IS6110 and IS1081) in Korean strains of Mycobacterium tuberculosis. Tuber Lung Dis (1995) 1.05
Bacillus Calmette-Guérin immunotherapy. Techniques and results. Urol Clin North Am (1992) 0.98
Possible hazards of routine bacillus Calmette-Guérin immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J (1996) 0.91
Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol (2001) 9.80
Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol (2000) 8.10
High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci U S A (2001) 6.97
Pertussis toxin gene: nucleotide sequence and genetic organization. Science (1986) 6.02
Identification of novel intergenic repetitive units in a mycobacterial two-component system operon. Mol Microbiol (1997) 3.99
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature (2001) 2.65
Two-partner secretion in Gram-negative bacteria: a thrifty, specific pathway for large virulence proteins. Mol Microbiol (2001) 2.58
Activation of the pro-drug ethionamide is regulated in mycobacteria. J Biol Chem (2000) 2.43
Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med (1996) 2.18
Isolation and molecular characterization of a novel broad-host-range plasmid from Bordetella bronchiseptica with sequence similarities to plasmids from gram-positive organisms. Mol Microbiol (1992) 2.16
Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect Immun (1994) 2.06
Green fluorescent protein as a new expression marker in mycobacteria. Mol Microbiol (1995) 1.97
Identification of a new DNA region specific for members of Mycobacterium tuberculosis complex. J Clin Microbiol (1998) 1.96
Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc Natl Acad Sci U S A (1986) 1.92
Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin. Infect Immun (1990) 1.83
Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin. FEMS Microbiol Lett (1991) 1.81
Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin. Proc Natl Acad Sci U S A (1998) 1.76
Beta-helix model for the filamentous haemagglutinin adhesin of Bordetella pertussis and related bacterial secretory proteins. Mol Microbiol (2001) 1.76
Rapid mycobacterial plasmid analysis by electroduction between Mycobacterium spp. and Escherichia coli. Nucleic Acids Res (1992) 1.75
Clonal expansion of a globally disseminated lineage of Mycobacterium tuberculosis with low IS6110 copy numbers. J Clin Microbiol (2004) 1.73
Cloning, partial sequence, expression, and antigenic analysis of the filamentous hemagglutinin gene of Bordetella pertussis. Infect Immun (1990) 1.66
Molecular cloning of pertussis toxin genes. Nucleic Acids Res (1986) 1.64
Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect Immun (1994) 1.54
The modular architecture of bacterial response regulators. Insights into the activation mechanism of the BvgA transactivator of Bordetella pertussis. J Mol Biol (1994) 1.50
Autotransporter proteins, evolution and redefining protein secretion: response. Trends Microbiol (2000) 1.48
Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol (1995) 1.48
Subtilisin-like autotransporter serves as maturation protease in a bacterial secretion pathway. EMBO J (2001) 1.48
Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis. Infect Immun (1994) 1.46
Identification and purification of transferrin- and lactoferrin-binding proteins of Bordetella pertussis and Bordetella bronchiseptica. Infect Immun (1991) 1.44
Efficient homologous recombination in fast-growing and slow-growing mycobacteria. J Bacteriol (1996) 1.39
Mutational analysis of the Bordetella pertussis fim/fha gene cluster: identification of a gene with sequence similarities to haemolysin accessory genes involved in export of FHA. Mol Microbiol (1994) 1.38
Distinct roles of the N-terminal and C-terminal precursor domains in the biogenesis of the Bordetella pertussis filamentous hemagglutinin. J Bacteriol (1996) 1.32
Characterization of the heparin-binding site of the mycobacterial heparin-binding hemagglutinin adhesin. J Biol Chem (2000) 1.31
Channel formation by FhaC, the outer membrane protein involved in the secretion of the Bordetella pertussis filamentous hemagglutinin. J Biol Chem (1999) 1.31
Repetitive sequences in Mycobacterium leprae and their impact on genome plasticity. Lepr Rev (2001) 1.30
Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine (2006) 1.29
New virulence-activated and virulence-repressed genes identified by systematic gene inactivation and generation of transcriptional fusions in Bordetella pertussis. J Bacteriol (2000) 1.29
First molecular epidemiology study of Mycobacterium tuberculosis in Burkina Faso. J Clin Microbiol (2007) 1.27
Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA:AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II. J Biol Chem (2001) 1.26
Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun (1987) 1.26
Identification of AlcR, an AraC-type regulator of alcaligin siderophore synthesis in Bordetella bronchiseptica and Bordetella pertussis. J Bacteriol (1998) 1.24
Lack of functional complementation between Bordetella pertussis filamentous hemagglutinin and Proteus mirabilis HpmA hemolysin secretion machineries. J Bacteriol (1997) 1.20
Novel topological features of FhaC, the outer membrane transporter involved in the secretion of the Bordetella pertussis filamentous hemagglutinin. J Biol Chem (2000) 1.20
Amino-terminal maturation of the Bordetella pertussis filamentous haemagglutinin. Mol Microbiol (1996) 1.18
Molecular characterization of the mycobacterial SenX3-RegX3 two-component system: evidence for autoregulation. Microbiology (2000) 1.15
Mycobacterium bovis Bacillus Calmette Guérin infection prevents apoptosis of resting human monocytes. Eur J Immunol (1997) 1.14
Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase. J Immunol (1996) 1.13
Molecular characterization of Bordetella bronchiseptica filamentous haemagglutinin and its secretion machinery. Microbiology (2000) 1.13
Immune system-dependent and -independent replication of the scrapie agent. J Virol (1996) 1.13
Functional complementation of a null mutation of the yeast Saccharomyces cerevisiae plasma membrane H(+)-ATPase by a plant H(+)-ATPase gene. J Biol Chem (1995) 1.11
Standardised PCR-based molecular epidemiology of tuberculosis. Eur Respir J (2007) 1.08
Evidence that a globular conformation is not compatible with FhaC-mediated secretion of the Bordetella pertussis filamentous haemagglutinin. Mol Microbiol (1998) 1.07
Differential modulation of Bordetella pertussis virulence genes as evidenced by DNA microarray analysis. Mol Genet Genomics (2003) 1.06
Bordetella pertussis TonB, a Bvg-independent virulence determinant. Infect Immun (2000) 1.04
Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis. Nat Biotechnol (1998) 1.03
Interaction of Bordetella pertussis with mast cells, modulation of cytokine secretion by pertussis toxin. Cell Microbiol (2001) 1.02
Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection. Infect Immun (2001) 1.02
Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein. Infect Immun (1994) 1.02
Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin. J Exp Med (1993) 1.01
Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen. Infect Immun (1997) 1.01
N-terminal characterization of the Bordetella pertussis filamentous haemagglutinin. Mol Microbiol (1998) 1.00
Role of DegP for two-partner secretion in Bordetella. Mol Microbiol (2009) 1.00
Mycobacterium smegmatis laminin-binding glycoprotein shares epitopes with Mycobacterium tuberculosis heparin-binding haemagglutinin. Mol Microbiol (2001) 0.99
Expression of the putative siderophore receptor gene bfrZ is controlled by the extracytoplasmic-function sigma factor BupI in Bordetella bronchiseptica. J Bacteriol (2001) 0.99
Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis. Proc Natl Acad Sci U S A (1996) 0.99
Ineffective cellular immune response associated with T-cell apoptosis in susceptible Mycobacterium bovis BCG-infected mice. Infect Immun (2000) 0.99
Immunodominant domains present on the Bordetella pertussis vaccine component filamentous hemagglutinin. J Infect Dis (1997) 0.99
Mercury resistance as a selective marker for recombinant mycobacteria. Microbiology (1995) 0.98
International spread of MDR TB from Tugela Ferry, South Africa. Emerg Infect Dis (2011) 0.97
Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis. Eur Respir J (2010) 0.96
Nasal vaccination using live bacterial vectors. Adv Drug Deliv Rev (2001) 0.96
Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium. Infect Immun (1998) 0.92
Recombinant HBHA boosting effect on BCG-induced immunity against Mycobacterium tuberculosis infection. Clin Dev Immunol (2011) 0.89
Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy. Vaccine (2009) 0.89
The yeast plasma membrane H(+)-ATPase. An essential change of conformation triggered by H+. J Biol Chem (1992) 0.89
In vivo immunomodulation following intradermal injection with DNA encoding IL-18. J Immunol (1999) 0.88
Characterization of the type III secretion locus of Bordetella pertussis. Int J Med Microbiol (2001) 0.86
The NAD-glycohydrolase activity of the pertussis toxin S1 subunit. Involvement of the catalytic HIS-35 residue. J Biol Chem (1994) 0.86
Green fluorescent protein as a reporter in rapid screening of antituberculosis compounds in vitro and in macrophages. Biochem Biophys Res Commun (1998) 0.86
Structure-based mechanism of ligand binding for periplasmic solute-binding protein of the Bug family. J Mol Biol (2007) 0.86
Monocyte-derived interleukin-10 depresses the Bordetella pertussis- specific gamma interferon response in vaccinated infants. Clin Vaccine Immunol (2009) 0.86
Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein. Infect Immun (1999) 0.85
Intracellular trafficking and membrane translocation of pertussis toxin into host cells. Int J Med Microbiol (2000) 0.85
Production of Neisseria meningitidis transferrin-binding protein B by recombinant Bordetella pertussis. Infect Immun (2001) 0.85
Review: subcellular traffic of the plasma membrane H(+)-ATPase in Saccharomyces cerevisiae. Yeast (1996) 0.85
Regulation of the expression of the H(+)-ATPase genes PMA1 and PMA2 during growth and effects of octanoic acid in Saccharomyces cerevisiae. Biochim Biophys Acta (1994) 0.85
Pathogenomics of mycobacteria. Genome Dyn (2009) 0.85
Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii. Vaccine (1999) 0.83
Tetanus toxin fragment C-specific priming by intranasal infection with recombinant Bordetella pertussis. Vaccine (2001) 0.82
The in vivo activation of Saccharomyces cerevisiae plasma membrane H(+)-ATPase by ethanol depends on the expression of the PMA1 gene, but not of the PMA2 gene. Yeast (1994) 0.82
Attenuated Bordetella pertussis vaccine strain BPZE1 modulates allergen-induced immunity and prevents allergic pulmonary pathology in a murine model. Clin Exp Allergy (2010) 0.82
Importance of ADP-ribosylation in the morphological changes of PC12 cells induced by cholera toxin. Infect Immun (1994) 0.82
Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD+. Biochem J (1990) 0.82
A new series of mycobacterial expression vectors for the development of live recombinant vaccines. Gene (1996) 0.82
Glutathione S-transferases of 28kDa as major vaccine candidates against schistosomiasis. Mem Inst Oswaldo Cruz (1998) 0.82